Mark S. Black - 20 May 2024 Form 4 Insider Report for Accelerate Diagnostics, Inc (AXDX)

Reporting relationship: Director
Issuer ticker: AXDX
Reported as of: 20 May 2024
Net transaction value: $0
SEC form: 4
Accepted by SEC: 21 May 2024, 19:04:51 UTC
Prior SEC filing: 01 Jun 2023
Source filing: View source filing
Reporting owner signature: /s/ David Patience, attorney-in-fact

Key filing fact

Mark S. Black filed Form 4 for Accelerate Diagnostics, Inc (AXDX) on 21 May 2024.

Key facts

This page summarizes Mark S. Black's Form 4 filing for Accelerate Diagnostics, Inc (AXDX).
1 reported transaction and 1 derivative row are listed below.
Accepted by SEC: 21 May 2024, 19:04.

Change

Previous filing in this sequence was filed on 01 Jun 2023.
Current net transaction value: $0.

Research use

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reported derivative securities

Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.

AXDX transaction Derivative

Restricted Stock Units

Award

Transaction value: $0
Shares: +66,667
Change %
Price: $0.000000
Shares after: 66,667
Date: 20 May 2024
Ownership: Direct
Underlying class: Common Stock
Underlying amount: 66,667
Exercise price
Footnotes: F1, F2

^* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 2 footnotes

Footnote F1

Each restricted stock unit ("RSU") represents a contingent right to receive one share of the issuer's common stock upon vesting.

Footnote F2

On May 20, 2024, the reporting person was granted a total of 66,667 RSUs, which vest on the first-year anniversary of the grant date, unless the reporting person leaves in good standing before such vesting date, in which case the RSUs will vest pro-rata based on months served. Pursuant to the issuer's Director Equity Deferral Program, the reporting person has elected to defer receipt of the shares of common stock upon vesting of the RSUs to such time that is within 30 days following the reporting person's departure from the issuer's board of directors.